The Australian medical community is excited with the emergence of retatrutide, a novel dual GIP and GLP-1 receptor agonist showing remarkable results in early trials for managing obesity. This medication https://harmonyecwn489835.tinyblogging.com/the-new-retatrutide-australia-a-potential-hope-for-weight-management-86408950